SUMMARY
Ras proteins on the inner leaflet of the plasma membrane signal from transient, nanoscale proteolipid assemblies called nanoclusters. Interactions between the Ras lipid anchors and plasma membrane phospholipids, cholesterol and actin cytoskeleton contribute to the formation, stability and dynamics of Ras nanoclusters. Many small biological molecules are amphiphilic and capable of intercalating into membranes and altering lipid immiscibility. In this study we systematically examined whether amphiphiles such as indomethacin influence Ras protein nanoclustering in intact plasma membrane.
We found that indomethacin, a nonsteroidal antiinflammatory drug, induced profound and complex effects on Ras spatial organization, all likely related to liquid-ordered domain stabilization. Indomethacin enhanced the clustering of H-Ras.GDP and N-ras.GTP in cholesterol dependent nanoclusters. Indomethacin also abrogated efficient GTPdependent lateral segregation of H-and N-ras between cholesterol-dependent and cholesterol-independent clusters resulting in mixed, heterotypic clusters of Ras proteins that normally are spatially separated. These heterotypic Ras nanoclusters showed impaired Raf recruitment and kinase activation resulting in significantly compromised MAPK signaling. All the amphiphilic anti-inflammatory agents we tested had similar effects on Ras nanoclustering and signaling. The potency of these effects correlated with the membrane partition coefficients of the individual agents and was independent of COX inhibition. This study shows that biological amphiphiles have wide-ranging effects on plasma membrane heterogeneity and protein nanoclustering and reveal a novel mechanism of drug action that has important consequences for cell signaling.
The small GTPase Ras regulates cell differentiation, proliferation and survival (1,2). The three major Ras isoforms that are ubiquitously expressed in mammalian cells, H-, K-and N-ras, contain a nearly identical Gdomain, which binds guanine nucleotides and interacts with downstream effectors, but have significantly divergent C-terminal hypervariable regions (HVR). H-, N-and K-ras are anchored to the inner surface of the plasma membrane by a C-terminal S-farnesyl cysteine carboxymethylester that operates in concert with a second signal in the HVR (3) . The second signal is one or two palmitoyl chains in N-and H-ras respectively, and a polybasic domain in KRas. On the plasma membrane, H-, K-and NRas proteins assemble into spatially distinct, highly dynamic nanoclusters with lifetimes of <1s and radii of <14nm that contain ~7 Ras proteins (4, 5) . Lateral segregation is also regulated by Ras activation, since GTP-loaded H-, N-and K-Ras proteins form nanoclusters that are spatially and structurally distinct from those formed by the cognate GDP-loaded proteins (5) (6) (7) . The formation of nanoclusters by Ras proteins is crucial to their signaling function (8) (9) (10) . The molecular mechanisms that drive nanoclustering involve a complex interplay of lipid-lipid and protein-lipid interactions between the membrane anchor, flanking protein sequences and lipids and proteins of the plasma membrane (4) (5) (6) 8, (11) (12) (13) . Given the critical role of plasma membrane lipids in nanocluster formation, any perturbation of the phospholipid membrane could potentially affect the spatiotemporal dynamics of Ras nanoclustering and signaling.
Many small biological molecules, such as nonsteroidal antiinflammatory drugs (NSAIDs) and bile salts, are amphiphilic and are capable of strong association with phospholipid bilayers. Indeed, our previous studies (14, 15) demonstrated that a potent NSAID, indomethacin, markedly alters the heterogeneity of synthetic phospholipid membranes. In the current study, we therefore systematically examined the ability indomethacin and other amphiphiles to perturb plasma membrane nanostructure using multiple Ras isoforms as spatiotemporal probes.
EXPERIMENTAL PROCEDURES
Materials-Indomethacin, aspirin, salicylate, ibuprofen and naproxen were purchased from Sigma-Aldrich (St. Louis, MO, USA) and prepared as described previously (14, 15) . Fluorescence Lifetime-Imaging Microscopy (FLIM) -Expression vectors for mGFP-and mRFP-linked -tH, H-ras, H-rasG12V, -tK, Kras, K-rasG12V, N-ras, N-rasG12V have been described (8) . Baby Hamster Kidney (BHK) cells cultured in DMEM containing 10% BCS were transfected using Lipofectamine according to manufacturer's instructions. Twenty-four hours after transfection, cells were treated with various concentrations of NSAIDs for 1h in DMEM, then washed and fixed with 4% paraformaldehyde. GFP fluorescence lifetime was measured using a Lambert Instruments (Roden, The Netherlands) FLIM attachment on a wide field Nikon microscope.
BHK cells expressing combinations of mGFP-and mRFPlinked constructs were excited using a sinusoidally modulated 3W 497 nm LED at 40 MHz under epi-illumination. Fluorescein at 1 µM was used as a lifetime reference standard. Cells were imaged with a 60x Plan-Apo/1.4 NA oil objective using an appropriate GFP filter set. The phase and modulation lifetimes were determined from a set of 12 phase settings using manufacturer's software. Three independent experiments were performed for each treatment and data from at least 60 cells were pooled to calculate mean and SEM. Tests for significant differences from control were performed by oneway ANOVA. Fluorescence lifetime FRET measurements have certain advantages over intensity-based methods, because fluorescence lifetime is an intrinsic property of the fluorescent molecule and is not influenced by factors, such as excitation source, detection gain, optical loss, variation in fluorophore concentration and is much less sensitive to variation in the donoracceptor ratio (assuming an excess of acceptor) (16) . Immuno-electron microscopy (EM) and spatial analysis-Immuno-EM and spatial analysis were conducted exactly as described previously (5, 7) . In brief, BHK cells were cultured on glass coverslips to ~80% confluency and treated with 75-100 µM indomethacin for 1h. Intact apical cell plasma membrane sheets were attached to EM grids, washed and fixed in 4% PFA, 0.1% gluteraldehyde. Grids were incubated with anti-GFP antisera directly coupled to 4.5nm gold, washed, stained in uranyl acetate and embedded in methylcellulose. Digital images of the immunogold labeled plasma membrane sheets were taken at 100,000x magnification in an electron microscope. Intact 1µm 2 areas of the plasma membrane sheet were identified and the (x,y) coordinates of each gold particle determined using ImageJ software. K-functions and transformations (5, 7, 17) (18, 19) and thus can be used to quantify the extent of clustering of gold particles. A value of L(r)-r value greater than the 99% confidence interval for a random pattern indicates statistically significant clustering. The magnitude of the peak L(r)-r value (L max ) correlates directly with the extent of clustering and the value of r at L max correlates with the radius of the clusters. Bootstrap tests can be used to examine for statistical differences between replicated point patterns. These bootstrap tests are constructed exactly as described (20) and statistical significance evaluated against 1000 bootstrap samples. A related analysis, the bivariate K-function, is used for quantifying the extent of co-clustering of two gold populations. Plasma membrane sheets prepared from cells co-expressing a GFP and RFP tagged protein are double labeled with anti-GFP directly coupled to 2nm gold and anti-RFP directly coupled to 6nm gold. EM images of the plasma membrane sheets are digitized as described above and the (x,y) coordinates of the small (2nm) gold particles and large (6nm) gold particles determined using ImageJ software. Bivariate K-functions and transformations (5, 7, 17) (6, 21) . To measure Raf kinase activity, BHK cells stably expressing either constitutively active H-ras.G12V or Kras.G12V were grown to 85-90% confluency and harvested. Membrane (P100) and cytoplasmic fractions (S100) were prepared by hypotonic lysis and high speed centrifugation and Raf kinase activity measured in P100 fractions in a coupled MEK / ERK kinase assay (21) .
RESULTS
Indomethacin enhances cholesterol-dependent nanoclusters in BHK cell plasma membrane. We previously reported that indomethacin at relatively high concentrations enhances liquidordered, L o , domain formation in model membranes and also enhances the nanoclustering of GFP-tH (= GFP targeted to the plasma membrane by the minimal membrane anchor of H-ras) in intact cells (15) . Here, we systematically examined the ability of indomethacin to alter nanocluster formation by full-length Ras proteins. GFP-tH nanoclusters are cholesterol dependent, as are nanoclusters of GDP-loaded full length H-ras (H-ras.GDP) and GTP-bound N-ras (N-ras.GTP) (7, 22) . We first used electron microscopic (EM) spatial mapping to explore whether therapeutically relevant concentrations (23, 24) of indomethacin have similar effects on the organization of these three types of Ras nanocluster. Spatial point pattern analysis of immunogold-labeled plasma membrane sheets prepared from BHK cells expressing GFP-tH, GFP-H-ras (H-ras.GDP) and oncogenic mutant GFP-N-rasG12V (Nras.GTP) all showed a marked increase in nanoclustering after 1h treatment with 75-100µM indomethacin as measured by Ripley's K-function (Figs. 1a-c). Indomethacin induced an increase in the peak L(r)-r value (L max ) and also the value of r at which L max occurs (r max ). Since r max and L max are correlated with the mean radius of the clusters and the mean number of proteins per cluster respectively (5), we conclude that indomethacin increases the size of, and/or stoichiometry of GFP-tH, H-ras.GDP and N-ras.GTP proteins in their respective nanoclusters. This result is consistent with a general effect of the indomethacin on enhancing L o domain stability in biological membranes. To compliment the EM studies, we examined molecular interactions within nanoclusters using fluorescence lifetime imaging microscopy combined with fluorescence resonance energy transfer (FLIM-FRET).
BHK cells were transiently transfected with GFP / RFP FRET pairs and GFP lifetime measured. FRET between GFP donor and RFP acceptor molecules within nanoclusters results in a reduction in donor lifetime (6, 15) . We found that GFP-tH expressed alone in BHK cells had a fluorescence lifetime of ~2.1ns, which was subsequently decreased to ~1.85ns when BHK cells co-expressed both GFP-tH and RFP-tH (Fig. 1d) . GFP-tH fluorescence lifetime in cells that co-express both GFP-tH and RFP-tH was further decreased to ~1.75ns when exposed to indomethacin at concentrations of 75-100µM (Fig. 1d) . GFP fluorescence lifetime was not affected by changes in fluorophore environment because the GFP fluorescence lifetime in cells expressing GFP-tH alone was not altered in the presence of indomethacin (data not shown). A similarly enhanced reduction in GFP lifetime on indomethacin treatment was also observed in BHK cells co-expressing GFP-and RFP-H-ras, or GFP-and RFP-N-rasG12V (Fig. 1d ). These data are concordant with the EM experiments in suggesting a generalized effect of indomethacin on enhancing the formation or stability of cholesterol-dependent nanoclusters in the plasma membrane.
Indomethacin has selective effects on cholesterol-independent clusters. We next tested the effect of indomethacin on the organization of Ras isoforms and mutants that form cholesterolindependent nanoclusters. EM spatial mapping showed that indomethacin had no effect on the extent of clustering of oncogenic mutant GFP-K-rasG12V (K-ras.GTP), which form cholesterol-independent nanoclusters, nor GFPtK (= GFP targeted to the plasma membrane by the minimal membrane anchor of K-ras), which co-localizes with GFP-K-rasG12V (Figs. 2a and b). Indomethacin also had no effect on the clustering of GFP-K-rasWT (K-ras.GDP) (data not shown). Similarly FLIM-FRET analysis of GFP/RFP pairs of the same proteins showed that indomethacin did not further reduce GFP fluorescence lifetime (Fig. 2e) , indicating no detectable effect of indomethacin on the molecular interactions between GFP-tK, Kras.GDP or active K-ras.GTP in their cognate cholesterol-independent nanoclusters.
In contrast, H-rasG12V, the constitutively active and oncogenic form of Hras (H-ras.GTP), displayed a different response to indomethacin. EM spatial analysis of GFP-HrasG12V on intact plasma membrane sheets showed a reduction in L max values when cells were treated with indomethacin ( Fig. 2c) , indicating a significant reduction of active Hras.GTP nanocluster formation in the plasma membrane. A concomitant reduction in r max shows that indomethacin treatment also reduced the diameter of H-ras.GTP nanoclusters. Inactive wild-type N-ras.GDP also forms cholesterol-independent nanoclusters. EM spatial analysis of GFP-N-rasWT expressing cells showed that indomethacin again significantly decreased L max (Fig. 2d) , similar to the effect observed on GFP-H-rasG12V. Paradoxically, FLIM-FRET imaging of cells expressing GFP/RFP FRET pairs of H-rasG12V or N-rasWT showed no increase in GFP fluorescence lifetime when cells were treated with indomethacin (Fig. 2f) . Thus although the EM analysis reported an indomethacin-induced reduction in nanoclustering, the FLIM-FRET analysis reported no overall change in the fraction of H-rasG12V or N-rasWT proteins within FRET distance of each other in their respective nanoclusters. Taken together these data suggest that indomethacin induces a more complex reorganization of H-ras.GTP and Nras.GDP nanoclusters than can be explained by a simple reduction in nanoclustering.
Indomethacin induces heterotypic H-ras nanocluster formation.
We previously showed that indomethacin significantly alters the lateral heterogeneity of model bilayer and cell plasma membranes (15) . It is therefore conceivable that indomethacin induces interaction between different nanoclusters that are normally spatially and structurally segregated. A commonality between H-ras and N-ras is that GTP/GDP loading regulates their lateral segregation between cholesterol-dependent and cholesterolindependent nanoclusters. We therefore tested whether indomethacin compromises this segregation by directly looking for heterotypic nanoclustering between GFP-tH (a surrogate marker of H-ras.GDP) and H-rasG12V, which normally form laterally segregated cholesteroldependent and cholesterol-independent nanoclusters, respectively. We first quantified the ability of indomethacin to drive heterotypic nanocluster formation between GFP-tH and RFP-H-rasG12V in the plasma membrane by immuno-EM. Plasma membrane sheets prepared from BHK cells co-expressing GFP-tH and RFP-H-rasG12V were labeled with 2nm anti-GFP-gold and 6nm anti-RFP-gold. The immunogold point patterns were evaluated using the bivariate K-function, L biv (r)-r, which quantifies the extent of co-localization of the two populations of gold particles. For control cells the L biv (r)-r was within the 99% C.I. indicating no detectable co-localization of GFP-tH and RFP-H-rasG12V (Fig. 3a) . However, treatment with indomethacin caused a marked increase in L biv (r)-r values above the 99% C.I. (Fig. 3a) , suggesting that indomethacin significantly induced co-clustering between GFP-tH and RFP-H-rasG12V in the plasma membrane. Using FLIM-FRET imaging, we observed a slight decrease in GFP-tH fluorescence lifetime in control cells co-expressing RFP-H-rasG12V indicating some degree of molecular proximity between GFP-tH and RFP-H-rasG12V molecules on the plasma membrane (Figs. 3b and c), as reported previously (6) . However, indomethacin induced a significant further decrease in GFP-tH fluorescence lifetime, indicating an enhanced interaction between GFP-tH and RFP-H-rasG12V and incorporation of both types of molecules within a single nanocluster, hence the formation of heterotypic nanoclusters.
A model that accounts for these results and the univariate EM and FLIM data of Fig. 2c and Fig. 2e is shown in Fig. 3d . We propose that H-ras.GTP is predominantly localized to homotypic, cholesterol-independent clusters, with a population of freely diffusing monomeric H-ras.GTP molecules. We further propose, based on the EM/FLIM data of Figs. 3a and b , the existence of a small population of H-ras.GTP in cholesterol-dependent nanoclusters containing GFP-tH molecules, called mixed, or heterotypic, nanoclusters. When cells are exposed to indomethacin, the drug stabilizes L o domains which enhances the formation or stability of both GFP-tH homotypic clusters and GFP-tH / H-ras.GTP heterotypic clusters. The stoichiometry of H-ras.GTP in mixed nanoclusters must be lower than in H-ras.GTP in homotypic nanoclusters, since heterotypic nanoclustering reduces the univariate L max value (Fig. 2c) , even though the overall fraction of GFP-/RFP-H-ras.GTP molecules within FRET distance of each other in the membrane does not change (Fig. 2f ). An identical model can account for the N-ras.GDP data by substituting Nras.GDP for H-ras.GTP in Fig.2d . In both cases, the effect of indomethacin on stabilizing L o domains has the consequence of impairing the GTP-dependent lateral segregation of H-and Nras resulting in the formation of mixed clusters of proteins that are normally efficiently segregated to spatially separated clusters.
Indomethacin drives co-clustering of L o domains with K-ras nanoclusters.
We next performed similar experiments to explore whether indomethacin induced an interaction between GFP-tH and K-ras nanoclusters. Plasma membrane sheets prepared from BHK cells coexpressing GFP-tH and RFP-K-rasG12V, were labeled with anti-GFP 2nm-gold and anti-RFP 6nm-gold and imaged by EM. The bivariate K function, L biv (r)-r showed no evidence of coclustering of GFP-tH and RFP-K-rasG12V under control conditions. Indomethacin at 75 and 100µM, however, significantly increased L biv (r)-r values (Fig. 4a) .
The r max for indomethacin-treated L biv (r)-r curve suggested a large domain radius (~50-60nm) for co-clustered GFP-tH and RFP-K-rasG12V proteins, compared with an r max of ≤30nm for homotypic nanoclusters of GFP-tH in the presence of indomethacin (Fig. 1a) and ≤20nm for GFP-tH and RFP-K-rasG12V nanoclusters under control conditions. In addition, univariate analyses of the GFP-tH 2nm-gold pattern and RFP-KrasG12V 6nm-gold pattern in the same experiment also returned r max values to 30-40nm. Taken together these spatial mapping data suggest that indomethacin induced the coassociation or aggregation of intact L o nanoclusters (GFP-tH) with intact cholesterolindependent nanoclusters (RFP-K-rasG12V), with no mixing of the constituent proteins of the two types of nanocluster. If this conclusion is correct and indomethacin is not driving the formation of homogeneously mixed nanoclusters between GFP-tH and RFP-K-rasG12V, then indomethacin treatment should not increase FRET between GFP-tH co-expressed with RFP-K-rasG12V. The FLIM-FRET data in Fig. 4b confirm this prediction. Identical results were obtained in immuno-EM and FLIM-FRET experiments between GFP-tH and RFP-tK or GFP-tH and RFP-KrasWT (data not shown). These results are summarized in the model shown in Fig. 4c . Note that in contrast to the indomethacin effect shown in Fig. 3 , this effect of indomethacin is related to an induced failure of lateral separation of otherwise intact and normally assembled nanoclusters.
Indomethacin inhibits Raf activation in Ras transformed cells. We next explored whether the indomethacin-induced changes in Ras nanoclustering have significant effects on Ras signal transmission. Raf is activated exclusively in Ras.GTP nanoclusters on the plasma membrane (9,10,21), therefore assays of Raf activation and Ras / Raf binding report directly on Ras nanocluster function. Figure 5a shows that indomethacin significantly inhibits Raf kinase activation by H-rasG12V and KrasG12V. Moreover, the FLIM experiments in Fig. 5b show that 100µM indomethacin significant increased (p<0.05) the fluorescence lifetime of GFP-K-ras.GTP or GFP-H-ras.GTP in the presence of RFP-CRaf, indicating that indomethacin weakens the molecular association between GFP-Ras.GTP and RFP-CRaf. These results are consistent with earlier studies showing that cholesterol-dependent clusters are suboptimal for Raf activation (21, 25) . Consistent with these results indomethacin pretreatment also significantly abrogated EGF stimulated MAPK activation in BHK cells (Figs. 5c and d).
NSAIDs perturb Ras nanoclustering at low therapeutic concentrations.
Although indomethacin concentrations as high as 160µM have been used therapeutically (23, 24) , the more common indomethacin plasma concentrations are in the range of 5 and 10µM. Using FLIM-FRET, we found that indomethacin at low doses of 5 and 10µM significantly decreased the fluorescence lifetime of GFP-tH, GFP-H-ras and GFP-N-rasG12V in BHK cells co-expressing the cognate RFP-tagged FRET pair (Fig. 6a) , while having no effect on GFP-K-rasG12V molecular interactions (Fig. 6b) . Indomethacin at 5 and 10µM also signficantly decreased the fluorescence lifetime of GFP-tH in cells coexpressing RFP-H-rasG12V, while having little effect on GFP-tH fluorescence lifetime in cells co-expressing GFP-tH and RFP-K-rasG12V (Figs. 6c and 6d) . These results therefore fully replicate with the effects observed with higher doses of indomethacin shown in Figures 1-5 .
Finally, to examine the generality of the effect of amphiphilic nonsteroidal antiinflammatory drugs (NSAIDs) on Ras nanoclustering and signaling, we screened four other drugs: aspirin, salicylate, naproxen, and ibuprofen. We found that all NSAIDs at their corresponding therapeutic concentrations induced a significant decrease in the fluorescence lifetime of GFP in cells coexpressing the FRET pair of GFP-tH/ RFP-tH (Fig. 7a) , similar to that seen with indomethacin. The same FLIM experiment was then performed using a fixed concentration of 25µM for all tested NSAIDs to compare their efficacy. Whereas the induced changes in the fluorescence lifetime of GFP-tH in the FRET assay did not correlate with IC 50 values against COX-1/COX-2 (Fig. 7b) , there was a strong correlation with the membrane partition coefficients of the NSAIDs (Fig. 7c) . Taken together these results strongly suggest that NSAID L o domain stabilization is related to the biophysical properties of the drugs not their ability to inhibit COX. Consistent with this interpretation, we found that salicylate, which does not inhibit COX at the tested concentration, also significantly inhibited EGF-stimulated activation of the MAPK cascade (Fig. 7d) .
DISCUSSION
We report here that biological amphiphiles, which include many anti-inflammatory agents, induce wide-ranging reorganization of plasma membrane nanostructure. Using different Ras isoforms as nanodomain markers we show that indomethacin stabilizes cholesterol-dependent nanoclusters and induces mixing of Ras proteins that normally segregate efficiently to cholesterol-independent nanoclusters. The mixing of proteins in what we term as heterotypic nanoclusters is of two types. The first class of heterotypic cluster results from a failure of GTP-dependent lateral segregation of H-ras and N-ras between cholesterol-dependent and cholesterol-independent nanoclusters, leading for example to mixed clusters of Hras.GTP and the lipid raft marker GFP-tH, which extensively co-clusters with H-ras.GDP. The second class of heterotypic cluster is visualized as an aggregation of cholesterol-dependent and cholesterol-independent nanoclusters that are normally spatially separated, as for example the association of K-ras.GTP nanoclusters with L o clusters containing GFP-tH. In this second class of mixed cluster there appears to be no actual mixing of the constituents of each type of nanocluster, which assemble normally, but form in the same region of the membrane instead of segregating to spatially distinct areas. Signal transmission by both classes of heterotypic cluster is compromised, as evidenced by reduced Raf recruitment and activation by H-ras.GTP or K-ras.GTP clusters in indomethacin treated cells. Ras-dependent Raf activation proceeds inefficiently in cholesterol-dependent nanoclusters (4, 21) , thus the presence of cholesterol within or near previously cholesterol-independent nanoclusters may account for the abrogated MAPK output. Although our detailed study focused on indomethacin all other anti-inflammatory amphiphiles that we tested has similar effects on Ras nanoclustering and signal output.
We propose that indomethacin-induced changes in nanoclustering originate from the ability of the amphiphilic agent to increase lipid immiscibility within the plasma membrane. We showed previously that indomethacin enhances phase separation in synthetic and biological membranes by increasing the fluidity and polarity of liquid-disordered, L d , domains (14, 15) .
These results are consistent with studies of synthetic model bilayers and computer simulations, which show that amphiphilic drugs, detergents, or more polar lipids, enhance or stabilize domain formation in gel-phase, L ophase or raft-like bilayers (26) (27) (28) (29) (30) (31) (32) . In the current study we observed a similar pattern set of effects of amphiphilic NSAIDs on the phase heterogeneity of biological cell plasma membranes with stabilization of cholesteroldependent or raft-like GFP-tH, H-ras.GDP and N-ras.GTP nanoclusters. The same biophysical mechanism may also account for the ability of indomethacin to impair the GTP-dependent lateral segregation of H-ras. A balance model has been used to describe how GTP-loading reorganizes H-ras membrane interactions (6, 8, 33) . The β2-β3 loop and helix α5 of the Hras G-domain act as a guanine nucleotide regulated switch (called switch III) that mediates competing interactions of helix α4 and basic residues in the HVR with polar lipids in the plasma (6, 8, 11) . When interactions of the HVR prevail, the palmitates of the C-terminal membrane anchor are highly ordered and the GDP-loaded H-ras protein is driven to L o nanoclusters (11). When H-ras is GTP-loaded, the interactions of helix α4 predominate, the palmitates are disordered and there is a major change in the orientation of the G-domain with respect to the membrane, which allows binding of scaffold proteins and assembly into cholesterol independent clusters (6, 8, 12) . We propose that changes in the polarity of the plasma membrane induced by NSAIDs interfere with the operation of switch III resulting in Hras.GTP retaining the orientation of H-ras.GDP with the associated ordered palmitates of the Cteminal anchor, resulting in co-assembly of Hras.GTP proteins into L o domains with Hras.GDP. Differential G-domain orientation also contributes to an increased rate of palmitate turnover on H-ras.GTP compared to H-ras.GDP. In the GDP-orientation the H-ras C-terminal anchor peptide is pulled deeper into the inner leaflet of the plasma membrane than when in the GTP-orientation, rendering the palmitoylthioester bonds of Cys181 and Cys184 less accessible to thioesterases (34) (35) (36) (37) (38) . Furthermore at least one major thioesterase, APT1, is palmitoylated and localizes to L d membrane (38,39). Thus the combined effects of NSAIDs in increasing in L o localization of Hras.GTP, so removing it from L d localized APT1, and potentially stabilizing H-ras.GTP in an aberrant H-ras.GDP orientation may together reduce the rate of palmitate turnover on Hras.GTP.
Indomethacin has no effect on the homotypic nanoclustering of K-ras. However electrostatic interactions between the K-ras polybasic domain and negatively charged polar lipids in the plasma membrane are critical for the formation of K-ras nanoclusters (40-46). In this context it is of interest that amphiphilic drugs, such as trifluoperazine, thioridazine, clozapine, chloropromazine, haloperidol, and cyclosporin, tend to preferentially partition into Clinical studies suggest that long-term daily intake of aspirin and other NSAIDs may significantly decrease the risk of death due to cancer by as much as 40% (51). Interestingly, aspirin is particularly effective against esophageal, colorectal and lung cancers (51), all of which express oncogenic K-ras with high frequency (52). Although it has been generally assumed that these chemopreventive effects of NSAIDs may be linked to their ability to inhibit COX, our findings here suggest that NSAIDs rather may act directly on the biophysical properties of the plasma membrane to modulate Ras signal transmission. More broadly this study represents the first demonstration that Ras spatiotemporal dynamics may be a viable drug target for therapeutic intervention. BIBLIOGRAPHY
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